RT Journal Article
SR Electronic
T1 Reopen or redistribute? ‐ Modeling years of life lost due to Covid-19, socioeconomic status, and non-pharmaceutical interventions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.23.21256005
DO 10.1101/2021.04.23.21256005
A1 John, Jari
YR 2021
UL http://medrxiv.org/content/early/2021/04/26/2021.04.23.21256005.abstract
AB Research in the current pandemic has put a sharp focus on the health burden of Covid-19, thereby largely neglecting the cost to life from the socioeconomic consequences of its containment. The paper develops a model for assessing their proportionality. It compares the years of lost life (YLL) due to Covid-19 and the socioeconomic consequences of its containment. The model reconciles the normative life table approach with de facto socioeconomic realities by correcting YLL estimates for socioeconomic differences in life expectancy. It thereby aims to improve on the attribution of YLL due to immediate and fundamental sources of inequalities in life expectancy. The application of the approach to the pandemic suggests that the socioeconomic consequences of containment measures come with a much higher life tag than the disease itself and therefore need urgent attention, especially in poorer and more unequal societies. Avoiding 3 million additional cases of extreme poverty may come with a similar life tag as protecting 1 million people from dying from Covid-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData openly available in a public repository that does not issue DOIs.